Evidence map›Paper›PMID 37088524›Full record

ReviewAdvances in kidney disease and health2023

Nonpharmacological Management of Autosomal Dominant Polycystic Kidney Disease.

Cortney N Steele, Kristen L Nowak

Open access · greenAbstract readReview
In one paragraph

Review in Advances in kidney disease and health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2025.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Cortney N SteeleDivision of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, CO.
Kristen L NowakDivision of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, CO. Electronic address: Kristen.Nowak@cuanschutz.edu.
University of Colorado Anschutz Medical Campus · US

Funding

Daily Caloric Restriction in Overweight and Obese Adults with ADPKDR01DK129259 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI NOWAK, KRISTEN LYNN · 2021 to 2025
$2.7M
Metabolome and Microbiome Profiling in Response to Dietary Interventions in Patients with ADPKDF32DK132836 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI STEELE, CORTNEY NICOLE · 2022 to 2023
$111k
NIDDK NIH HHS F32 DK132836NIDDK NIH HHS R01 DK129259
6 · The paper itself

Abstract

Autosomal dominant polycystic kidney disease is a slowly progressive, lifelong disease characterized by continuous development and enlargement of kidney cysts. Thus, nonpharmacological interventions are crucial in disease management and have the potential for a large clinical impact as standalone interventions or in conjunction with pharmacological therapies. Current potential strategies regarding nonpharmacological management of autosomal dominant polycystic kidney disease include nonpharmacological management of blood pressure, calorie restriction, weight loss or weight management, enhanced hydration, limiting caffeine, dietary sodium restriction, protein restriction or altering the type of protein intake, phosphorus restriction, and reducing net acid load. This brief review discusses the available evidence, including cell culture, animal, epidemiological, and clinical studies, regarding the utility of such strategies in the nonpharmacological management of autosomal dominant polycystic kidney disease. We assert that lifestyle modification strategies should be a critical aspect of the treatment of autosomal dominant polycystic kidney disease, while further trial and mechanistic evidence continue to become available.

Indexed as

Kidney NeoplasmsPolycystic Kidney, Autosomal DominantSodium, DietaryAnimalsBlood PressureSodium Chloride, DietarySodium Chloride, DietarySodium, DietaryDietHydrationObesityPolycystic kidney diseaseSodium

Identifiers

PMID37088524
PMCPMC10353837
OpenAlexW4366608519

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.